PALO ALTO, Calif. and
BEIJING, July 6, 2020 /PRNewswire/ -- Varian (NYSE: VAR)
today announced it received the "Best After-Sales Service
Award for Radiotherapy Products" in the 2019 Chinese Medical
Devices Industry Data and After-Sales Service Survey for the third
year in a row. Varian also led in metrics of Market Share,
Repurchasing Reference, and Net Promoter Score.
The 10th annual survey, which was organized by
China Medical Equipment magazine, collected responses this
time from more than 2,000 hospitals across 32 provinces in the
country. The survey is dedicated to improving medical devices'
after-sale services systems.
The results of the survey were announced via virtual
presentation. In the radiotherapy linear accelerator category,
Varian led the competition by 8 percentage points in market share
category, and 6.2 percentage points in the Net Promoter Score
category.
During the virtual presentation, Varian introduced its
cloud-based Intelligent Cancer Care solution and explained how by
deploying these solutions during the COVID-19 pandemic it allowed
users to resume collaborations between medical partnerships.
Clinicians, who either couldn't travel or provide support onsite
because of social distancing, could connect via remote tools.
The cloud-based Intelligent Cancer Care solution can build an
information-driven network that can bring people, data, and
technology together to realize a more intelligent and efficient
approach to cancer care.
"We are very honored to receive the award again, " said Dr.
Zhang Xiao, president of Varian
Greater China region. "We believe technology is key to closing the
huge gap between access and need. Only by accelerating the
combination of human intelligence with the power of data and
technology can we rapidly improve the efficiency of medical
resources and quality of treatments, taking us forward to a world
without fear of cancer."
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 10,000 employees across 70 countries
keep the patient and our clinical partners at the center of our
thinking as we power new victories in cancer care. Because, for
cancer patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow @VarianMedSys
on Twitter.
Press Contact
Helen Yang
Manager, Greater China Public Relations
+86 (10) 87836354
helen.yang@varian.com
Investor Relations Contact
Anshul Maheshwari
Vice President, Investor Relations
+1 (650) 424-5631
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-wins-best-after-sales-service-award-for-radiotherapy-products-in-china-for-third-year-in-a-row-301088130.html
SOURCE Varian